There are many definitions of supply chain integration, but the one that we use in this thesis is the following:
• Supply chain integration is “merging of more than one vertical supply chain for specified programs or product categories” (Yadav et al., 2014, p. 6726).
As part of my thesis, I have created a short survey to obtain the feedback of the Immunization experts on what could be the possible impacts of the integration of the immunization supply chain with the one of the essential of medicines on the performance of the immunization program.
I know you are all very much busy with the daily activities, but I will be grateful if you could please take 10min to complete the survey as your responses will ineluctably help my research. The survey will be opened for 6 weeks as of May 2022. The survey results will be further disseminated via TechNet21 forum. The link to the survey is the following:
https://docs.google.com/forms/d/e/1FAIpQLSevXWct-3bNf7sCaqjOBNr-5CkPJha9kesoo0uNPuWQCSxWOw/viewform
Please be informed that the data collected will only be used for my DBA dissertation and thus for only academic purposes.
In case you have any questions, or you wish to receive a copy of the survey results, please feel free to let me know via my contact details below.
I thank you in advance,
Hamadou
E-mail: [email protected]
Cell : +221781586968
WhatsApp : +41767865248
Scholars who successfully complete the course are expected to be able to:
- Describe...
Scholars who successfully complete the course are expected to be able to:
- Describe IA2030’s seven strategic priorities and four core principles.
- Identify strategic priorities and focus areas that are likely to transform your national immunization programme and the work of global partners.
- Define the problem and prioritize recommendations to select a suggested action that could have the greatest impact on the current state in your country.
- Identify best practices in the suggested action through literature review and dialogue with your peers.
- Explore innovative ways to implement strategic priorities in your country context.
- Compare and share best practices with practitioners from all over the world, drawing on global expertise from WHO.
This interactive digital course in English and French is most suitable for those directly supporting national immunization planning. The following groups are encouraged to apply:
- national EPI management staff, WHO/UNICEF country and regional staff, in-country partner organization staff
female immunization staff
- sub-national staff directly involved in immunization planning
Please do share the call for applications with trusted colleagues and networks.
Application link (deadline: 31 August 2021)
https://www.learning.foundation/who-immunization-agenda-2030
The course is also available in French. Application link in FRENCH:
https://www.learning.foundation/who-immunization-agenda-2030-fr
More about the WHO Immunization Scholar platform: https://www.who.int/teams/immunization-vaccines-and-biologicals/essential-programme-on-immunization/training/general
Do you use the Telegram app on your phone or desktop? TechNet has just created a telegram group in EN where immunization professionals will have the opportunity to chat, connect, learn, share information, etc. We also plan to...
Do you use the Telegram app on your phone or desktop? TechNet has just created a telegram group in EN where immunization professionals will have the opportunity to chat, connect, learn, share information, etc. We also plan to invite experts from WHO, UNICEF, PATH, and other key partners to interact with the members of this channel during special events and discussions. The group is private and can be joined only via this invitation link that you can share with your relevant network: https://t.me/joinchat/Iioww1fT0gT84z6IdGQp-w Join us and let's start discussing!
In addition, we have opened an announcement channel where we'll share links to interesting events, documents, etc. You can join this channel here: https://t.me/joinchat/AAAAAEM2oIAXIRKtpJQOCg
We're looking for to interacting with you soon! If you have any question, please don't hesitate to reply to this message.
Warm regards,
Alex
Do you have to face this kind of problematic in your professional...
Do you have to face this kind of problematic in your professional environment? What is your approach? What do you think of the expert's view in this article?
Data management systems are key for providing logistic data end to end visibility but only if they “talk” to each other. VillageReach, Luke International, and MoH Malawi explore in this conference session how the Government of Malawi is using...
Data management systems are key for providing logistic data end to end visibility but only if they “talk” to each other. VillageReach, Luke International, and MoH Malawi explore in this conference session how the Government of Malawi is using Chipatala cha pa Foni Hotline Data, a Health Centre by Phone initiative, to Inform COVID-19 related Decision-Making.
Do you have any experience with toll free mobile phone hotlines to get information on health? If yes, what's your experience? What do you think of such tools? How can such a tool be useful to support Covid response?
Video: https://youtu.be/j0n4FHmld84
Presentation: https://www.technet-21.org/en/library/main/6667-interoperability-of-data-management-system-to-support-covid-response-in-malawi-
The demand for cold chain storage has increased as more temperature-sensitive health products become available for primary health care service delivery. What could be the practical solution to safely manage the storage and transport of these...
The demand for cold chain storage has increased as more temperature-sensitive health products become available for primary health care service delivery. What could be the practical solution to safely manage the storage and transport of these products without causing too much burden on the cold chain? Learn from countries achieving supply chain efficiency through an integrated approach.
Do you have any experience with integration? What do you think of this approach?
How much more are we willing to pay for a vaccine that can be used outside the cold chain? Are the trade-offs of paying more for a CTC-qualified vaccine worthwhile? How and when is CTC a good investment for national immunization programs? This...
How much more are we willing to pay for a vaccine that can be used outside the cold chain? Are the trade-offs of paying more for a CTC-qualified vaccine worthwhile? How and when is CTC a good investment for national immunization programs? This presentation will address these questions, presenting the key economic arguments in favour of CTC implementation from a country perspective.
Have you heard of or have any experience with CTC?
Let us know if you have any question!
Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second dose of measles containing vaccine (MCV2) is well below the 95% target of immunized children. Consequently, there were over...
Measles and rubella vaccines are safe and effective, however, achieving equitable coverage, particularly for the second dose of measles containing vaccine (MCV2) is well below the 95% target of immunized children. Consequently, there were over 140,000 deaths globally, in 2018.
Novel and improved vaccine delivery platforms such as microarray patches (MAPs) are needed to address the increasing challenge of achieving and sustaining effective vaccination of MRVs, to achieve the eradication of measles and rubella, a goal set by the WHO and partners. MAPs offer competitive advantages over needle and syringe (NS) vaccine delivery:
- They have a potential to be more thermostable and freeze resistant
- They do not require reconstitution resulting in an improved safety profile
- They are easier to use, do not contain sharps
- They are more acceptable by caregivers and vaccinees.
Measles and rubella MAPs (MR-MAPs) will soon enter phase one clinical trials and although early in development, critical actions are needed to prepare the pathway for late stage product development and mitigate against delays in scale up.
How, where and when are we going to use microarray patches to deliver #measles and #rubella vaccines?
The recording and the presentation of the TechNet Conference session on OpenLMIS are now available.
End visibility of logistic data is a key factor for ensuring products availability to our communities. During this session, we will look at the...
The recording and the presentation of the TechNet Conference session on OpenLMIS are now available.
End visibility of logistic data is a key factor for ensuring products availability to our communities. During this session, we will look at the latest OpenLMIS CoVID edition as a rapid adaptation of a global good to support supply chains during COVID.
Presentation: https://www.technet-21.org/en/library/main/6666-openlmis-covid-edition-to-support-supply-chains-during-covid
Did you miss the TechNet conference session on the Vaccine Innovation Prioritisation Strategy (VIPS)?
VIPS represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates...
Did you miss the TechNet conference session on the Vaccine Innovation Prioritisation Strategy (VIPS)?
VIPS represents an unprecedented three-year collaboration between the Gavi Secretariat, World Health Organization (WHO), Bill & Melinda Gates Foundation (BMGF), United Nations Children’s Fund (UNICEF) and PATH – known as the VIPS Alliance - to develop a single integrated framework to evaluate and prioritise innovations in vaccine product delivery that meet country needs. The goal of VIPS is to provide greater clarity to manufacturers and partners to inform and influence investment decisions, and to drive these innovations forward. This presentation discusses the prioritisation process, the 3 prioritised innovations / approaches and the proposed next steps to advance them.
So make yourself some coffee or tea, and enjoy the content!